Resources

This data file contains statistical data about Australia's COVID-19 vaccinations.

This document contains the terms of reference for the Environmental Health Standing Committee (enHealth).

This public summary document outlines a Stoma Product Assessment Panel (SPAP) recommendation to reject listing the Omnigon SG3 AMPatch Stoma Cover in subgroup 9(m) of the Stoma Appliance Scheme (SAS) Schedule.

This public summary document outlines a Stoma Product Assessment Panel (SPAP) recommendation to delete 6 products from the current product range of Omnigon BBraun Flexima Active (SAS Code 80142B) in subgroup 2(b) of the Stoma Appliance Scheme (SAS) Schedule.

This public summary document outlines a Stoma Product Assessment Panel (SPAP) recommendation to list Omnigon KomfortLite Support Belt in subgroup 9(h) of the Stoma Appliance Scheme (SAS) Schedule.

This public summary document outlines a Stoma Product Assessment Panel (SPAP) recommendation to reject listing the Omnigon F3 AMPatch Stoma Cover in subgroup 9(m) of the Stoma Appliance Scheme (SAS) Schedule.

This public summary document outlines a Stoma Product Assessment Panel (SPAP) recommendation to reject listing the Omnigon Post-Op AMPatch Stoma Cover in subgroup 9(m) of the Stoma Appliance Scheme (SAS) Schedule.

This public summary document outlines a Stoma Product Assessment Panel (SPAP) recommendation to delete 6 products from the current product range of Omnigon BBraun Flexima Active (SAS Code 80165F) in subgroup 3(b) of the Stoma Appliance Scheme (SAS) Schedule.

This public summary document outlines a Stoma Product Assessment Panel (SPAP) recommendation to list ConvaTec Sur-Fit Natura Urostomy Pouch in subgroup 7(a) of the Stoma Appliance Scheme (SAS) Schedule.

This public summary document outlines a Stoma Product Assessment Panel (SPAP) recommendation to list ConvaTec Sur-Fit Natura Urostomy Pouch in subgroup 7(a) of the Stoma Appliance Scheme (SAS) Schedule.

This public summary document outlines a Stoma Product Assessment Panel (SPAP) recommendation to delete 6 products from the current product range of Omnigon BBraun Flexima Active (SAS Code 80165F) in subgroup 3(b) of the Stoma Appliance Scheme (SAS) Schedule.

This public summary document outlines a Stoma Product Assessment Panel (SPAP) recommendation to delete 6 variants in the existing product range of Omnigon BBraun Flexima Active (SAS Code 80142B) in subgroup 2(b) of the Stoma Appliance Scheme (SAS) Schedule.

This public summary document outlines a Stoma Product Assessment Panel (SPAP) recommendation to reject listing the Omnigon F3 AMPatch Stoma Cover in subgroup 9(m) of the Stoma Appliance Scheme (SAS) Schedule.

This report, and accompanying table, provide a fortnightly summary on notifications of Australia's nationally notifiable diseases for 27 June to 10 July 2022.

This certification statement, signed by Secretary Brendan Murphy on 15 July 2022, certifies that the COVID-19 campaign complies with relevant guidelines and policies.

This public summary document outlines a Stoma Product Assessment Panel (SPAP) recommendation to list ConvaTec Natura Durahesive Skin Barrier in subgroup 4(a) of the Stoma Appliance Scheme (SAS) Schedule.

This public summary document outlines a Stoma Product Assessment Panel (SPAP) recommendation to list ConvaTec Natura Two-Piece Drainable Pouch in subgroup 6(a) of the Stoma Appliance Scheme (SAS) Schedule.

Frequently asked questions about the Practitioner Review Program.

This public summary document outlines a Stoma Product Assessment Panel (SPAP) recommendation to list ConvaTec Sur-Fit Natura Urostomy Pouch in subgroup 7(a) of the Stoma Appliance Scheme (SAS) Schedule.

This public summary document outlines a Stoma Product Assessment Panel (SPAP) recommendation to list the Omnigon BBraun Flexima Active in subgroup 2(b) of the Stoma Appliance Scheme (SAS) Schedule.

This presentation, delivered on 22 July 2022, contains an update to Australia's COVID-19 vaccine rollout.

Information on the definition of inappropriate practice and how it applies to practitioners and corporate entities.